Literature DB >> 11991608

Hyperendothelinemia and ICG clearance in alcoholic and nonalcoholic cirrhosis.

Shigeo Maruyama1, Chisato Hirayama, Satoru Yamamoto, Masaharu Koda, Akihiro Udagawa, Yoshiro Kadowaki, Masayuki Inoue, Atsushi Sagayama, Kensuke Umeki.   

Abstract

Plasma endothelin (ET) levels are generally increased in cirrhosis patients in line with the severity of disease; however, the pathophysiological significance remains to be clarified. We evaluated the plasma ET levels in 49 patients with alcoholic cirrhosis and in 53 patients with nonalcoholic cirrhosis of the same disease severity. The plasma ET level was significantly elevated in alcoholic patients (P < 0.0001) and slightly so in nonalcoholic patients (P < 0.01); the difference was significant between the groups (P < 0.0001). The plasma ET level was positively correlated with the Child-Pugh score (P < 0.0001) and negatively correlated with prothrombin index (P < 0.001) and indocyanine green (ICG) clearance (P < 0.0001). The plasma ET level decreased 32% in alcoholic patients after abstinence (P < 0.001), but remained correlated with ICG clearance (P < 0.001) and the Child-Pugh score (P < 0.01), but not with prothrombin index. Regression analysis revealed that the plasma ET level was correlated with estimated hepatic blood flow and alcohol abuse. These findings suggest that hyperendothelinemia in cirrhosis patients is related to alcohol abuse and disease severity, especially to impaired hepatic hemodynamics.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11991608     DOI: 10.1023/a:1014787916342

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  28 in total

1.  THE EFFECT OF ETHANOL UPON SYSTEMIC AND HEPATIC BLOOD FLOW IN MAN.

Authors:  S W Stein; C S Lieber; C M Leevy; G R Cherrick; W H Abelmann
Journal:  Am J Clin Nutr       Date:  1963-08       Impact factor: 7.045

2.  The use of indocyanine green for the evaluation of hepatic function and blood flow in man.

Authors:  B D WIEGAND; S G KETTERER; E RAPAPORT
Journal:  Am J Dig Dis       Date:  1960-05

3.  Effect of intravenous infusions of ethanol upon estimated hepatic blood flow in man.

Authors:  A I MENDELOFF
Journal:  J Clin Invest       Date:  1954-10       Impact factor: 14.808

4.  Hyperdynamic circulation in patients with cirrhosis: direct measurement of nitric oxide levels in hepatic and portal veins.

Authors:  S Battista; F Bar; G Mengozzi; E Zanon; M Grosso; G Molino
Journal:  J Hepatol       Date:  1997-01       Impact factor: 25.083

5.  Production and release of endothelin-1 from the gut and spleen in portal hypertension due to cirrhosis.

Authors:  N Nagasue; D K Dhar; A Yamanoi; Y Emi; J Udagawa; A Yamamoto; M Tachibana; H Kubota; H Kohno; T Harada
Journal:  Hepatology       Date:  2000-05       Impact factor: 17.425

6.  Plasma concentration of endothelin-1 does not reflect renal vasoconstriction as estimated by duplex ultrasonography in cirrhosis.

Authors:  H Kitamura; R Shimada; A Kobayashi; K Nomura; T Noike; H Harada; S Miyagawa; S Kawasaki
Journal:  Dig Dis Sci       Date:  1997-03       Impact factor: 3.199

7.  Plasma endothelin levels in chronic ethanol fed rats: relationship to pathologic liver injury.

Authors:  A A Nanji; S Khwaja; U Khettry; S M Sadrzadeh
Journal:  Life Sci       Date:  1994       Impact factor: 5.037

8.  Correlation of intrahepatic pressure with collagen in the Disse space and hepatomegaly in humans and in the rat.

Authors:  H Orrego; L M Blendis; I R Crossley; A Medline; A Macdonald; S Ritchie; Y Israel
Journal:  Gastroenterology       Date:  1981-03       Impact factor: 22.682

9.  Clinical significance of plasma endothelin-1 in patients with chronic liver disease.

Authors:  H Matsumoto; J Uemasu; M Kitano; H Kawasaki
Journal:  Dig Dis Sci       Date:  1994-12       Impact factor: 3.199

10.  Enhanced endothelium-dependent vasodilation in patients with cirrhosis.

Authors:  A Albillos; I Rossi; G Cacho; M V Martínez; I Millán; L Abreu; C Barrios; P Escartín
Journal:  Am J Physiol       Date:  1995-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.